These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Loss of substantia nigra hyperintensity on 7 Tesla MRI of Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Kim JM; Jeong HJ; Bae YJ; Park SY; Kim E; Kang SY; Oh ES; Kim KJ; Jeon B; Kim SE; Cho ZH; Kim YB Parkinsonism Relat Disord; 2016 May; 26():47-54. PubMed ID: 26951846 [TBL] [Abstract][Full Text] [Related]
5. Progressive supranuclear palsy and Parkinson's disease overlap: A clinicopathological case report. Araki K; Sumikura H; Matsudaira T; Sugiura A; Takao M; Murayama S; Obi T Neuropathology; 2016 Apr; 36(2):187-91. PubMed ID: 26388542 [TBL] [Abstract][Full Text] [Related]
6. Apraxia in Parkinson's disease, progressive supranuclear palsy, multiple system atrophy and neuroleptic-induced parkinsonism. Leiguarda RC; Pramstaller PP; Merello M; Starkstein S; Lees AJ; Marsden CD Brain; 1997 Jan; 120 ( Pt 1)():75-90. PubMed ID: 9055799 [TBL] [Abstract][Full Text] [Related]
7. Comparison of dystonia between Parkinson's disease and atypical parkinsonism: The clinical usefulness of dystonia distribution and characteristics in the differential diagnosis of parkinsonism. Yoon WT Neurol Neurochir Pol; 2018; 52(1):48-53. PubMed ID: 29196058 [TBL] [Abstract][Full Text] [Related]
8. Measurement of the dopaminergic degeneration in Parkinson's disease with [123I] beta-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy. Brücke T; Asenbaum S; Pirker W; Djamshidian S; Wenger S; Wöber C; Müller C; Podreka I J Neural Transm Suppl; 1997; 50():9-24. PubMed ID: 9120429 [TBL] [Abstract][Full Text] [Related]
9. Urodynamic and neurophysiological evaluation in Parkinson's disease and multiple system atrophy. Stocchi F; Carbone A; Inghilleri M; Monge A; Ruggieri S; Berardelli A; Manfredi M J Neurol Neurosurg Psychiatry; 1997 May; 62(5):507-11. PubMed ID: 9153611 [TBL] [Abstract][Full Text] [Related]
11. Patterns of brain atrophy in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy. Messina D; Cerasa A; Condino F; Arabia G; Novellino F; Nicoletti G; Salsone M; Morelli M; Lanza PL; Quattrone A Parkinsonism Relat Disord; 2011 Mar; 17(3):172-6. PubMed ID: 21236720 [TBL] [Abstract][Full Text] [Related]
12. A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. Bukhatwa S; Zeng BY; Rose S; Jenner P Brain Res; 2010 Apr; 1326():174-83. PubMed ID: 20176003 [TBL] [Abstract][Full Text] [Related]
13. Neuropathology of Parkinson's disease and related syndromes. Gibb WR Neurol Clin; 1992 May; 10(2):361-76. PubMed ID: 1584179 [TBL] [Abstract][Full Text] [Related]
14. Sleep disturbances and brain MRI morphometry in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy - a comparative study. Gama RL; Távora DG; Bomfim RC; Silva CE; de Bruin VM; de Bruin PF Parkinsonism Relat Disord; 2010 May; 16(4):275-9. PubMed ID: 20185356 [TBL] [Abstract][Full Text] [Related]
15. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation. Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734 [TBL] [Abstract][Full Text] [Related]
16. Parkinson's disease associated with argyrophilic grains clinically resembling progressive supranuclear palsy: an autopsy case. Seno H; Kobayashi S; Inagaki T; Yamamori C; Miyaoka T; Horiguchi J; Wada M; Harada T J Neurol Sci; 2000 Sep; 178(1):70-4. PubMed ID: 11018253 [TBL] [Abstract][Full Text] [Related]
17. Glucose metabolism in the cortical and subcortical brain structures in multiple system atrophy and Parkinson's disease: a positron emission tomographic study. Otsuka M; Ichiya Y; Kuwabara Y; Hosokawa S; Sasaki M; Yoshida T; Fukumura T; Kato M; Masuda K J Neurol Sci; 1996 Dec; 144(1-2):77-83. PubMed ID: 8994107 [TBL] [Abstract][Full Text] [Related]
18. Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy. Rusz J; Bonnet C; Klempíř J; Tykalová T; Baborová E; Novotný M; Rulseh A; Růžička E J Neurol; 2015; 262(4):992-1001. PubMed ID: 25683763 [TBL] [Abstract][Full Text] [Related]
19. Pallido-nigro-luysian atrophy, progressive supranuclear palsy and adult onset Hallervorden-Spatz disease: a case of akinesia as a predominant feature of parkinsonism. Yamamoto T; Kawamura J; Hashimoto S; Nakamura M; Iwamoto H; Kobashi Y; Ichijima K J Neurol Sci; 1991 Jan; 101(1):98-106. PubMed ID: 1709202 [TBL] [Abstract][Full Text] [Related]
20. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. Santangelo G; Cuoco S; Pellecchia MT; Erro R; Barone P; Picillo M J Neurol; 2018 Nov; 265(11):2602-2613. PubMed ID: 30178175 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]